Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIPO-202 for central abdominal bulging in obese subjects
NCT02568319Phase 2Completed
- Sponsor
- Neothetics
- Start
- Sep 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of salmeterol, sponsored by Neothetics. Started Sep 2015; status: completed.
02
Drugs
salmeterol
Beyond the preview
Go deeper on NCT02568319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02568319.